GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (LTS:0QAV) » Definitions » Dividend-Payout-to-FFO

Nanobiotix (LTS:0QAV) Dividend-Payout-to-FFO


View and export this data going back to 2016. Start your Free Trial

What is Nanobiotix Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Nanobiotix Business Description

Traded in Other Exchanges
Address
60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.